TW
Inquiry Cart

Chemical materials

RG-7652 (anti-PCSK9) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot

RG-7652 (anti-PCSK9) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot

AB183277-100ΜG / 100ΜG
Add to Inquiry
RG-7652 (anti-PCSK9) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot

RG-7652 (anti-PCSK9) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot

AB183277-10MG / 10MG
Add to Inquiry
RG-7652 (anti-PCSK9) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot

RG-7652 (anti-PCSK9) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot

AB183277-1MG / 1MG
Add to Inquiry
RG-7652 (anti-PCSK9) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot

RG-7652 (anti-PCSK9) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot

AB183277-5MG / 5MG
Add to Inquiry
Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)

Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)

AB183313-100ΜG / 100ΜG
CAS No.：1826843-81-5
Add to Inquiry
Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)

Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)

AB183313-10MG / 10MG
CAS No.：1826843-81-5
Add to Inquiry
Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)

Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)

AB183313-1MG / 1MG
CAS No.：1826843-81-5
Add to Inquiry
Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)

Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)

AB183313-5MG / 5MG
CAS No.：1826843-81-5
Add to Inquiry
Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183314-100ΜG / 100ΜG
CAS No.：2238831-60-0
Add to Inquiry
Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183314-10MG / 10MG
CAS No.：2238831-60-0
Add to Inquiry
Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183314-1MG / 1MG
CAS No.：2238831-60-0
Add to Inquiry
Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183314-5MG / 5MG
CAS No.：2238831-60-0
Add to Inquiry
Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183315-100ΜG / 100ΜG
CAS No.：2227102-46-5
Add to Inquiry
Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183315-10MG / 10MG
CAS No.：2227102-46-5
Add to Inquiry
Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183315-1MG / 1MG
CAS No.：2227102-46-5
Add to Inquiry
Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183315-5MG / 5MG
CAS No.：2227102-46-5
Add to Inquiry
Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot

Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot

AB183317-100ΜG / 100ΜG
CAS No.：2136633-23-1
Add to Inquiry
Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot

Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot

AB183317-10MG / 10MG
CAS No.：2136633-23-1
Add to Inquiry
Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot

Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot

AB183317-1MG / 1MG
CAS No.：2136633-23-1
Add to Inquiry
Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot

Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot

AB183317-5MG / 5MG
CAS No.：2136633-23-1
Add to Inquiry
Farletuzumab-MMAE (anti-FOLR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Farletuzumab-MMAE (anti-FOLR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183319-100ΜG / 100ΜG
Add to Inquiry
Farletuzumab-MMAE (anti-FOLR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Farletuzumab-MMAE (anti-FOLR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183319-10MG / 10MG
Add to Inquiry
Farletuzumab-MMAE (anti-FOLR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Farletuzumab-MMAE (anti-FOLR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183319-1MG / 1MG
Add to Inquiry
Farletuzumab-MMAE (anti-FOLR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Farletuzumab-MMAE (anti-FOLR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183319-5MG / 5MG
Add to Inquiry
Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183320-100ΜG / 100ΜG
CAS No.：1906205-77-3
Add to Inquiry
Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183320-10MG / 10MG
CAS No.：1906205-77-3
Add to Inquiry
Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183320-1MG / 1MG
CAS No.：1906205-77-3
Add to Inquiry
Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183320-5MG / 5MG
CAS No.：1906205-77-3
Add to Inquiry
Zilovertamab vedotin (anti-ROR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Zilovertamab vedotin (anti-ROR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183321-100ΜG / 100ΜG
Add to Inquiry
Zilovertamab vedotin (anti-ROR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Zilovertamab vedotin (anti-ROR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183321-10MG / 10MG
Add to Inquiry
Zilovertamab vedotin (anti-ROR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Zilovertamab vedotin (anti-ROR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183321-1MG / 1MG
Add to Inquiry
Zilovertamab vedotin (anti-ROR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Zilovertamab vedotin (anti-ROR1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183321-5MG / 5MG
Add to Inquiry
Ozuriftamab vedotin (anti-ROR2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Ozuriftamab vedotin (anti-ROR2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183322-100ΜG / 100ΜG
CAS No.：2460400-11-5
Add to Inquiry
Ozuriftamab vedotin (anti-ROR2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Ozuriftamab vedotin (anti-ROR2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183322-10MG / 10MG
CAS No.：2460400-11-5
Add to Inquiry
Ozuriftamab vedotin (anti-ROR2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Ozuriftamab vedotin (anti-ROR2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183322-1MG / 1MG
CAS No.：2460400-11-5
Add to Inquiry
Ozuriftamab vedotin (anti-ROR2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Ozuriftamab vedotin (anti-ROR2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183322-5MG / 5MG
CAS No.：2460400-11-5
Add to Inquiry
Pinatuzumab vedotin (anti-CD22) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Pinatuzumab vedotin (anti-CD22) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183323-100ΜG / 100ΜG
CAS No.：1313706-14-7
Add to Inquiry
Pinatuzumab vedotin (anti-CD22) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Pinatuzumab vedotin (anti-CD22) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183323-10MG / 10MG
CAS No.：1313706-14-7
Add to Inquiry
Pinatuzumab vedotin (anti-CD22) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Pinatuzumab vedotin (anti-CD22) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183323-1MG / 1MG
CAS No.：1313706-14-7
Add to Inquiry
Pinatuzumab vedotin (anti-CD22) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Pinatuzumab vedotin (anti-CD22) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183323-5MG / 5MG
CAS No.：1313706-14-7
Add to Inquiry
Sofituzumab vedotin (anti-MUC16) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Sofituzumab vedotin (anti-MUC16) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183328-100ΜG / 100ΜG
CAS No.：1418200-58-4
Add to Inquiry
Sofituzumab vedotin (anti-MUC16) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Sofituzumab vedotin (anti-MUC16) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183328-10MG / 10MG
CAS No.：1418200-58-4
Add to Inquiry
Sofituzumab vedotin (anti-MUC16) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Sofituzumab vedotin (anti-MUC16) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183328-1MG / 1MG
CAS No.：1418200-58-4
Add to Inquiry
Sofituzumab vedotin (anti-MUC16) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Sofituzumab vedotin (anti-MUC16) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183328-5MG / 5MG
CAS No.：1418200-58-4
Add to Inquiry
Ladiratuzumab vedotin (anti-SLC39A6) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Ladiratuzumab vedotin (anti-SLC39A6) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183329-100ΜG / 100ΜG
CAS No.：1629760-29-7
Add to Inquiry
Ladiratuzumab vedotin (anti-SLC39A6) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Ladiratuzumab vedotin (anti-SLC39A6) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183329-10MG / 10MG
CAS No.：1629760-29-7
Add to Inquiry
Ladiratuzumab vedotin (anti-SLC39A6) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Ladiratuzumab vedotin (anti-SLC39A6) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183329-1MG / 1MG
CAS No.：1629760-29-7
Add to Inquiry
Ladiratuzumab vedotin (anti-SLC39A6) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Ladiratuzumab vedotin (anti-SLC39A6) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183329-5MG / 5MG
CAS No.：1629760-29-7
Add to Inquiry
Enapotamab vedotin (anti-Axl) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Enapotamab vedotin (anti-Axl) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183333-100ΜG / 100ΜG
CAS No.：1912424-97-5
Add to Inquiry
Enapotamab vedotin (anti-Axl) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

Enapotamab vedotin (anti-Axl) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot

AB183333-10MG / 10MG
CAS No.：1912424-97-5
Add to Inquiry
LOCATIONS

Service location

Taipei, New Taipei, Keelung / Yilan / Hualien
  • Taipei, New Taipei, Keelung / Yilan / Hualien
  • Taoyuan
  • Hsinchu County / Hsinchu City / Miaoli
  • Taichung/Changhua/Nantou
  • Yunlin/Chiayi/Tainan
  • Kaohsiung/Pingtung/Taitung

Taipei Branch

Address 5th Floor, No. 10, Lane 50, Section 3, Nangang Road, Nangang District, Taipei City
Telephone 02-2786-2331
Fax 02-2653-6959
Mail taipei@echochemical.com

Taoyuan Branch

Address 2nd Floor, No. 62, Fuxing Street, Pingzhen District, Taoyuan City
Telephone 03-494-6939
Fax 03-493-0687
Mail chungli@echochemical.com

Head Office / Zhumen Branch

Address No. 16, Gongye Road, Toufen City, Miaoli County
Telephone 037-621-088
Fax 037-615-096
Mail miaoli@echochemical.com

Taichung Branch

Address 15F-2, No. 218, Section 1, Wenxin Road, Nantun District, Taichung City
Telephone 04-2472-8859
Fax 04-2472-8825
Mail taichung@echochemical.com

Tainan Branch

Address No. 33, Lane 63, Yanzhou 1st Street, Yongkang District, Tainan City
Telephone 06-243-6589
Fax 06-253-8208
Mail tainan@echochemical.com

Kaohsiung Branch

Address No. 479, Fengding Road, Fengshan District, Kaohsiung City
Telephone 07-753-9988
Fax 07-753-1958
Mail kaohsiung@echochemical.com
北北基/宜蘭/花蓮 桃園 新竹縣/新竹市/苗栗 台中/彰化/南投 雲林/嘉義/台南 高雄/屏東/台東
mapNorth
mapTaoyuan
mapHsinchu
mapCentral
mapYunlin
mapSouth
TW
Inquiry Cart
Inquiry Cart

Your inquiry Cart total 0 items

Inquiry Form
In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
Manage Cookies

Privacy Preference Center

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
View Privacy Policy

Manage Consent Settings

Necessary Cookies

Enable all
The operation of the website relies on these cookies, and you cannot disable them in the system. These cookies are usually set based on the actions you take (i.e., service requests), such as setting privacy preferences, logging in, or filling out forms. You can set your browser to block or prompt you about these cookies, but this may cause some website functions to stop working.